Shijiazhuang Yiling Pharmaceutical (002603.SZ) announced that its wholly-owned subsidiary Peking Yiling Pharmaceutical Co., Ltd. ("Peking Yiling") received the "Drug Clinical Trial Approval Notification" issued by the National Medical Products Administration on December 12, 2024.
According to reports, Lianhua Yuping Granules are Innovative Drugs guided by the theory of Traditional Chinese Medicine in the prevention and treatment of respiratory diseases, based on Prescriptions for the Purpose of Resisting Wind and Gathering Nutrition, Cinnamon Decoction, and Silver-queried Powder, for treating symptoms of cold with Qi deficiency. Its proposed functions and indications are: to tonify Qi and strengthen the body's defenses, dispel wind and detoxify. It is suitable for cold with Qi deficiency syndrome, which presents with symptoms such as aversion to wind, fear of cold, nasal congestion, runny nose, fever, sore throat, accompanied by fatigue, weakness, shortness of breath, reluctance to speak, spontaneous sweating, pale complexion, tongue with a pale coating, thin white coating, and pulse floating and thin or weak.
It is said that Lianhua Yuping Granules are a Traditional Chinese Medicine Innovative Drug developed based on the theory of meridian diseases for the prevention and treatment of respiratory system diseases, tailored from Yupingfeng Powder, Guizhi Decoction, and Yingqiao Powder to treat the symptoms of cold and Qi deficiency. The proposed functions are: invigorating Qi, strengthening the defense, dispelling wind, and detoxifying. It is suitable for cold with Qi deficiency, with symptoms such as aversion to wind, fear of cold, nasal congestion, runny nose, fever, sore throat, accompanied by fatigue, weakness, shortness of breath, reluctance to speak, spontaneous sweating, pale complexion, pale tongue, thin white coating, and floating thin or weak pulse.
Comment(0)
Reason For Report